CHA₂DS₂-VA Score for Atrial Fibrillation Stroke Risk

id

10583

full_title

CHA₂DS₂-VA Score for Atrial Fibrillation Stroke Risk

short_title

CHA₂DS₂-VA Score

med_description

Calculates stroke risk for patients with atrial fibrillation; similar to theCHA₂DS₂-VASc Scorebut without considering sex.

description

The CHA₂DS₂-VA Score for Atrial Fibrillation Stroke Risk calculates stroke risk for patients with atrial fibrillation; similar to CHA₂DS₂-VASc score but without considering gender.

keywords

CHA₂DS₂-VA Score for Atrial Fibrillation Stroke Risk, CHA₂DS₂-VA Score, CHADS, CHA2DS2, CHADS2, CHADS VA, CHA2DS2 VA, CHADS VASc, CHA2DS2 VASc, stroke AF, stroke risk, atrial fibrillation stroke, stroke prediction AF, AF stroke risk, stroke, AF, CHADS AF, CHADS stroke, CHA2DS2 AF, CHA2DS2 stroke

complaint

[ "Altered Mental Status", "Arrhythmia", "Dizziness", "Headache", "Neurologic Deficit", "Palpitations", "Preventive Care/Screening", "Syncope", "Weakness", "Dysarthria", "Dysphagia" ]

formula

The CHA₂DS₂-VA Score is determined by adding the selected points for each variable:

evidence

measurements

[]

information

Interpretation:

refrences

{ "Clinical Practice Guidelines": [ { "href": "https://pubmed.ncbi.nlm.nih.gov/39210723/", "text": "Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 esc guidelines for the management of atrial fibrillation developed in collaboration with the european association for cardio-thoracic surgery(Eacts). European Heart Journal. 2024;45(36):3314-3414." } ], "Manufacturer Website": [], "Original/Primary Reference": [ { "href": "https://pubmed.ncbi.nlm.nih.gov/39217497/", "text": "Champsi A, Mobley AR, Subramanian A, et al. Gender and contemporary risk of adverse events in atrial fibrillation. European Heart Journal. 2024;45(36):3707-3717." } ], "Other References": [], "Outcomes": [], "Validation": [ { "href": "https://pubmed.ncbi.nlm.nih.gov/39171253/", "text": "Teppo K, Lip GYH, Airaksinen KEJ, et al. Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (Finacaf) cohort. The Lancet Regional Health - Europe. 2024;43:100967." } ], "Validations": [] }

pearls

The inclusion of sex as an independent risk factor for ischemic stroke in patients with AF has been controversial; this score does not include sex in its risk assessment.

usecase

Use in patients with atrial fibrillation (AF) who do not have a prior history of stroke or transient ischemic attack (TIA) and are under consideration for anticoagulation therapy.

reasons

Assesses a patient’s risk for ischemic stroke and can help identify patients who may benefit from anticoagulation therapy to prevent thromboembolic events. Has a predictive value similar to theCHA₂DS₂-VASc Scorebut may be superior in patients ≥75 years of age. Recommended as a risk assessment model in the European Society of Cardiology (ESC) guidelines for the management of AF.

next_advice

• Use the results of this tool to guide the management of thromboembolic risk in AF, alongside comprehensive evaluation, clinical judgment, specialty recommendations, and patient preference. 
• Reassess stroke risk at periodic intervals.

next_actions

next_management

• Score of ≥2: 

  • Oral anticoagulation is recommended to reduce stroke risk.

  • Consider using a bleeding risk score (e.g., ATRIA, DOAC, HAS-BLED, HEMORR₂HAGES, ORBIT) to assess bleeding risk.

• Score of 1: Use clinical judgment to weigh the risks and benefits of anticoagulation.

• Score of 0: Anticoagulation is not recommended.

• Please see the ESC guidelines for the management of AF for additional recommendations.

diseases

[ "Atrial Fibrillation", "Bleeding/Hemorrhage", "Intracranial Hemorrhage", "Thrombosis", "Stroke / Transient Ischemic Attack (TIA)" ]

instructions

published

2024-11-13T15:29:42.274Z

purpose

[ "Prognosis" ]

search_terms

[ "CHA₂DS₂-VA Score for Atrial Fibrillation Stroke Risk", "CHA₂DS₂-VA Score", "CHADS", "CHA2DS2", "CHADS2", "CHADS VA", "CHA2DS2 VA", "CHADS VASc", "CHA2DS2 VASc", "stroke AF", "stroke risk", "atrial fibrillation stroke", "stroke prediction AF", "AF stroke risk", "stroke", "AF", "CHADS AF", "CHADS stroke", "CHA2DS2 AF", "CHA2DS2 stroke" ]

seo

{ "keywords_en": "CHA₂DS₂-VA Score for Atrial Fibrillation Stroke Risk, CHA₂DS₂-VA Score, CHADS, CHA2DS2, CHADS2, CHADS VA, CHA2DS2 VA, CHADS VASc, CHA2DS2 VASc, stroke AF, stroke risk, atrial fibrillation stroke, stroke prediction AF, AF stroke risk, stroke, AF, CHADS AF, CHADS stroke, CHA2DS2 AF, CHA2DS2 stroke", "meta_description_en": "The CHA₂DS₂-VA Score for Atrial Fibrillation Stroke Risk calculates stroke risk for patients with atrial fibrillation; similar to CHA₂DS₂-VASc score but without considering gender." }

specialty

[ "Cardiology", "Family Practice", "Hospitalist Medicine", "Internal Medicine", "Neurology", "Primary Care" ]

departments

[ "Cardiac", "Neurologic", "Vascular" ]

tags

[]

version_number

1

versions

[]

related

[ { "calcId": 801, "short_title_en": "CHA₂DS₂-VASc Score", "slug": "cha2ds2-vasc-score-atrial-fibrillation-stroke-risk" }, { "calcId": 10504, "short_title_en": "GARFIELD-AF", "slug": "garfield-af" }, { "calcId": 40, "short_title_en": "CHADS₂ Score", "slug": "chads2-score-atrial-fibrillation-stroke-risk" } ]

ismed

false

section

[ "whenToUseViewed", "pearlsPitfallsViewed", "whyUseViewed", "nextStepsViewed", "evidenceViewed" ]

cleaned_departments

[ "cardiology", "neurology", "cardiology" ]

cleaned_use

[ "Use in patients with atrial fibrillation (AF) who do not have a prior history of stroke or transient ischemic attack (TIA) and are under consideration for anticoagulation therapy." ]

pub

true